247  Total SME IPOs listed in 2024

9572.65 Crs.  Total funds raised in 2024

223  SME IPOs listed with Gain in 2024

24  SME IPOs listed with loss in 2024

247  Total SME IPOs listed in 2024

9572.65 Crs.  Total funds raised in 2024

223  SME IPOs listed with Gain in 2024

24  SME IPOs listed with loss in 2024

247  Total SME IPOs listed in 2024

9572.65 Crs.  Total funds raised in 2024

223  SME IPOs listed with Gain in 2024

24  SME IPOs listed with loss in 2024

247  Total SME IPOs listed in 2024

9572.65 Crs.  Total funds raised in 2024

223  SME IPOs listed with Gain in 2024

24  SME IPOs listed with loss in 2024

Thyrocare Technologies Limited IPO (Thyrocare Technologies IPO) Details

Thyrocare Technologies Limited is an Healthcare based company, located in Mumbai, Thyrocare Technologies Limited IPO size was 479.21 Cr. and was issued at 446.00 per share. The share of Thyrocare Technologies Limited were listed at 618.10 per share and are currently trading at 826.05 per share.

Type :
Sub Sector : Diagnostic Chains And Conducts An Array Of Medical Diagnostic Tests And Profiles Of Tests That Center
MainBoard IPO

Financial Summary (at the time of ipo, on annualised basis)

Revenue :
240.63 Cr.

PAT :
53.36 Cr.

Pricing Report

Issue Price :
446.00

Listing Price :
618.10

Current Market Price :
826.05

Issue Price vs CMP :
380.05 (85.21%)

listing Price vs CMP :
207.95 (33.64%)

Performance Report (CAGR* wise)

CAGR : 7.34
-ve 0 6 9 12+
Above Average

*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.

About Thyrocare Technologies

Company Information
Thyrocare Technologies Limited is one of India's leading pan-India diagnostic chains, offering a wide range of medical diagnostic tests and profiles aimed at the early detection and management of various disorders and diseases. As of November 30, 2015, the company provided 192 tests and 54 test profiles to detect conditions such as thyroid disorders, growth disorders, metabolism disorders, autoimmunity, diabetes, anemia, cardiovascular diseases, infertility, and infectious diseases.

The company also offers 17 test profiles under the "Aarogyam" brand, focusing on wellness and preventive healthcare tests. It operates its testing services through a fully automated CPL (Centralized Processing Laboratory) and has expanded to include a network of Regional Processing Labs (RPLs). Since the opening of the RPLs in 2015, the volume of tests conducted has
Show More
Object of Issue
  • Achieve the benefits of listing the Equity Shares on the BSE and the NSE and
  • Offer for sale

Thyrocare Technologies MainBoard IPO Details (at the time of IPO)

IPO Type :
Book Building
IPO Date :
May, 2016
IPO Size :
479.21 Cr.
IPO Subscription :
73.55 X     
PE Multiple :
45.00
Merchant Banker :
Edelweiss Financial Services Limited
IPO Registrar:
Link Intime India Private Limited

Thinking of
Listing Your Business through
SME IPO?

We can Help!

Contact Us Today

See Other MainBoard IPOs in Mumbai

Abans Holdings Limited

  financial service arm of the well-diversified Abans group

  Mumbai



Advanced Enzyme Technologies Limited

  research and development manufacturing and marketing of healthcare products

  Mumbai


Peer Companies Of This Sector

FAQs

Thyrocare Technologies operates in Healthcare and Diagnostic Chains And Conducts An Array Of Medical Diagnostic Tests And Profiles Of Tests That Center. The Issue is listed on MainBoard in May, 2016. Thyrocare Technologies IPO size was 479.21 Cr. with Issue price of 446.00 .

Merchant Banker(s) of Thyrocare Technologies IPO: Edelweiss Financial Services Limited , ICICI Securities Limited , Jm Financial Limited

Thyrocare Technologies IPO subscription was 73.55 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.

Thyrocare Technologies IPO listed at a listing price of 618.10 against the offer price of 446.00.

The current market price of Thyrocare Technologies is 826.05.

Services

IPO Advisory
IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Readiness
IPO Readiness
IPO Roadmap by improving Business Efficiencies, Financial Parameters and Corporate Structure to become IPO ready.
Fund Raising
Fund Raising
Fuelling a company's growth through Pre IPO Fund Raise, Private Equity, and Angel Investing.
SME : Business Scaling
SME Business Upscaling
Provide support to build a scalable SME business by unleashing the SME potential.
Post IPO Montoring
Post IPO Mentoring
Assisting with post IPO regulatory requirements and Performance Monitoring to achieve the milestone of Mainboard migration.

Thinking of
Listing Your Business through SME IPO?

We can help! Contact Us

Why Us?

  • Leading portal for IPOs
  • End to End Solutions
  • Known for Transparency